Diagnostic features of polycystic ovary syndrome
Date
2006
Authors
Barday-Karbanee N.
Siebert T.I.
Botha M.H.
Kruger T.F.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
androstenedione, clomifene citrate, follitropin, gonadotropin, hydroxyprogesterone, luteinizing hormone, oral contraceptive agent, testosterone, thyrotropin, amenorrhea, androstenedione blood level, cancer research, cancer risk, cardiovascular disease, cardiovascular risk, clinical feature, clinical practice, consensus development, correlation analysis, cost effectiveness analysis, diagnostic accuracy, diagnostic value, disease association, endometrium cancer, endometrium carcinoma, estrogen blood level, female, follitropin blood level, genetic linkage, gonadotropin blood level, human, hyperandrogenism, hyperinsulinemia, hypertension, impaired glucose tolerance, incidence, insulin resistance, luteinizing hormone blood level, menopause, menstrual irregularity, metabolic syndrome X, non insulin dependent diabetes mellitus, nuclear magnetic resonance imaging, obesity, oligomenorrhea, ovary polycystic disease, pathogenesis, pathophysiology, phenotype, practice guideline, prediction, prevalence, race difference, review, risk assessment, risk factor, standard, statistical significance, testosterone blood level, three dimensional imaging, thyrotropin blood level, transvaginal echography
Citation
South African Journal of Obstetrics and Gynaecology
12
1
12
1